SKI Market

Indian Indices

Nifty

22,302.50 0.00
(0.00%)

Sensex

72,929.45 -536.94
( -0.73%)

Bank Nifty

48,021.10 -264.25
( -0.55%)

Nifty IT

33,335.15 -137.85
( -0.41%)

Global Indices

Nasdaq

16,302.76 -29.80
(-0.18%)

Dow Jones

39,056.39 172.13
(0.44%)

Hang Seng

18,313.86 -165.51
(-0.90%)

Nikkei 225

38,202.37 -632.73
(-1.63%)

Forex

USD-INR

83.48 0.01
(0.01%)

EUR-INR

89.85 -0.05
(-0.05%)

GBP-INR

104.64 -0.22
(-0.21%)

JPY-INR

0.54 0.00
(-0.43%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Laurus Labs Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

540222

INE947Q01028

78.057879

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

LAURUSLABS

104.61

23399.2

EPS(TTM)

Face Value()

Div & Yield %

4.15

0.09

Back

id info business services ltd

ID Info Business Services reports standalone nil net profit/loss in the September 2023 quarter

Nov 09,2023

ID Info Business Services reported no net profit/loss in the quarter ended September 2023 as against net profit of Rs 0.06 crore during the previous quarter ended September 2022. Sales declined 87.50% to Rs 0.01 crore in the quarter ended September 2023 as against Rs 0.08 crore during the previous quarter ended September 2022.

Particulars	Quarter Ended
	Sep. 2023	Sep. 2022	% Var.
Sales	0.01	0.08	-88
OPM %	0	75.00	-
PBDT	0	0.06	-100
PBT	0	0.06	-100
NP	0	0.06	-100

22,302.50 0.00 (0.00%)

72,929.45 -536.94 ( -0.73%)

48,021.10 -264.25 ( -0.55%)

33,335.15 -137.85 ( -0.41%)

16,302.76 -29.80 (-0.18%)

39,056.39 172.13 (0.44%)

18,313.86 -165.51 (-0.90%)

38,202.37 -632.73 (-1.63%)

83.48 0.01 (0.01%)

89.85 -0.05 (-0.05%)

104.64 -0.22 (-0.21%)

0.54 0.00 (-0.43%)